News
A three-year-old girl has become the youngest patient in the UK to receive a groundbreaking gene therapy for a rare, ...
Recent developments in U.S. domestic affairs include a legal victory for Anthropic in an AI training lawsuit, Treasury ...
But after receiving the new gene therapy, called Upstaza, Gunreet has made progress that her mother thought would never be ...
The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts.
Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have discovered a ...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is a commercial-stage biopharmaceutical company that discovers and develops ...
Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell ...
Sensorineural hearing loss (SNHL) is the most prevalent form of permanent hearing loss, affecting over 6% of the global ...
In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations ...
Genetically engineered skin grafts exhibited a long-term ability to heal large, chronic wounds in patients with recessive ...
Sangamo Therapeutics’ investigational gene therapy appears to improve kidney function at 52 weeks for patients with a rare genetic disorder. | Sangamo Therapeutics’ investigational gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results